Profile data is unavailable for this security.
About the company
Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.
- Revenue in JPY (TTM)177.34bn
- Net income in JPY16.55bn
- Incorporated2021
- Employees3.48k
- LocationSawai Group Holdings Co Ltd5-2-30, Miyahara, Yodogawa-kuOSAKA-SHI 532-0003JapanJPN
- Phone+81 661055818
- Websitehttps://www.sawaigroup.holdings
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Torii Pharmaceutical Co Ltd | 58.84bn | 5.28bn | 137.09bn | 583.00 | 25.36 | 1.11 | 24.06 | 2.33 | 187.71 | 187.71 | 2,093.33 | 4,271.84 | 0.4411 | 2.74 | 2.30 | 100,924,500.00 | 3.96 | 6.52 | 4.39 | 7.35 | 44.46 | 49.55 | 8.97 | 17.98 | 5.19 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Towa Pharmaceutical Co Ltd | 243.94bn | 15.78bn | 145.28bn | 4.59k | 8.80 | 0.8725 | 4.20 | 0.5955 | 320.50 | 320.50 | 4,956.02 | 3,232.16 | 0.5838 | 1.52 | 3.93 | 53,169,570.00 | 3.78 | 4.21 | 4.56 | 5.63 | 36.10 | 39.23 | 6.47 | 7.23 | 1.63 | -- | 0.581 | 21.01 | 9.13 | 16.74 | 634.80 | 3.72 | 28.20 | 10.86 |
| Kissei Pharmaceutical Co Ltd | 81.07bn | 10.73bn | 180.23bn | 1.78k | 15.12 | 0.7356 | 11.80 | 2.22 | 241.71 | 241.71 | 1,825.83 | 4,969.03 | 0.3294 | 1.60 | 2.98 | 45,568,860.00 | 4.38 | 3.61 | 4.75 | 3.90 | 49.88 | 49.47 | 13.31 | 12.69 | 4.15 | -- | 0.0057 | 34.87 | 11.98 | 0.8919 | 6.00 | 15.28 | 6.58 | 10.40 |
| KAKEN PHARMACEUTICAL CO., LTD. | 87.25bn | 18.24bn | 204.94bn | 1.14k | 9.26 | 1.09 | 9.81 | 2.35 | 481.71 | 481.71 | 2,303.80 | 4,076.80 | 0.4864 | 1.98 | 3.88 | 76,867,840.00 | 10.17 | 6.83 | 11.66 | 7.87 | 60.66 | 54.78 | 20.91 | 14.48 | 4.47 | -- | 0.0243 | 51.25 | -1.29 | -5.21 | 47.52 | -14.70 | 0.3639 | 0.00 |
| Sumitomo Pharma Co Ltd | 342.67bn | -279.46bn | 242.32bn | 4.98k | -- | 2.12 | -- | 0.7072 | -703.41 | -703.41 | 862.50 | 287.37 | 0.3517 | 1.30 | 4.28 | 68,808,230.00 | -28.68 | -5.07 | -51.21 | -7.73 | 59.56 | 69.99 | -81.54 | -12.28 | 0.424 | -12.10 | 0.7732 | -- | -43.38 | -7.29 | -322.71 | -- | 4.02 | -- |
| Sawai Group Holdings Co Ltd | 177.34bn | 16.55bn | 259.26bn | 3.48k | 15.58 | 1.21 | 9.13 | 1.46 | 126.61 | 184.41 | 1,357.79 | 1,623.19 | 0.4658 | 1.12 | 2.83 | 50,929,920.00 | 3.17 | 0.7104 | 4.24 | 0.9705 | 30.73 | 35.08 | 6.80 | 1.47 | 1.39 | 38.13 | 0.3169 | 88.13 | 8.04 | -0.8249 | 46.82 | -2.33 | 18.15 | 0.00 |
| Nippon Shinyaku Co., Ltd. | 154.27bn | 26.05bn | 294.07bn | 2.21k | 10.82 | 1.20 | 9.31 | 1.91 | 386.74 | 386.74 | 2,290.53 | 3,486.81 | 0.5956 | 1.29 | 3.36 | 69,711,700.00 | 10.06 | 10.45 | 11.39 | 12.31 | 67.69 | 61.27 | 16.89 | 16.47 | 4.22 | -- | 0.0107 | 32.62 | 2.83 | 5.26 | 13.32 | 9.66 | 45.93 | 12.12 |
| Hisamitsu Pharmaceutical Co Inc | 150.19bn | 14.65bn | 364.25bn | 2.76k | 21.91 | 1.15 | 17.47 | 2.43 | 195.20 | 195.20 | 1,996.17 | 3,730.09 | 0.4323 | 3.01 | 3.22 | 54,434,580.00 | 4.36 | 4.22 | 5.25 | 4.82 | 56.42 | 58.62 | 10.10 | 10.03 | 3.14 | -- | 0.004 | 53.05 | 10.42 | -0.2385 | 18.97 | -6.17 | 28.90 | 0.5989 |
| Tsumura & Co | 164.61bn | 25.20bn | 372.89bn | 4.14k | 14.64 | 1.25 | 9.73 | 2.27 | 331.93 | 331.93 | 2,167.87 | 3,875.47 | 0.3783 | 0.6916 | 2.48 | 39,781,050.00 | 6.23 | 4.81 | 7.63 | 5.89 | 48.76 | 50.98 | 16.48 | 12.65 | 3.04 | -- | 0.1806 | 32.16 | 7.71 | 4.52 | 1.37 | 2.74 | 17.54 | 5.84 |
Data as of Nov 25 2024. Currency figures normalised to Sawai Group Holdings Co Ltd's reporting currency: Japanese Yen JPY
31.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 30 Jul 2024 | 10.17m | 7.74% |
| Nomura Asset Management Co., Ltd.as of 15 Nov 2024 | 8.37m | 6.37% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 3.94m | 3.00% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Oct 2024 | 3.76m | 2.86% |
| JPMorgan Asset Management (Japan) Ltd.as of 15 Nov 2024 | 3.48m | 2.65% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 15 Nov 2024 | 2.79m | 2.12% |
| FIL Investments (Japan) Ltd.as of 30 Sep 2024 | 2.32m | 1.76% |
| Nikko Asset Management Co., Ltd.as of 15 Oct 2024 | 2.20m | 1.67% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 2.02m | 1.54% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 1.96m | 1.49% |
More ▼
Data from 30 Jun 2024 - 21 Nov 2024Source: FactSet Research Systems Inc.
